{"SPADE_N_01509": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 10464975 B2", "Patent Link": "http://www.lens.org/lens/patent/US_10464975_B2", "Patent Type": "Granted Patent", "Publication Date": "2019-11-5", "Family Info": "CA2989311A1,WO2017004591A2,US20170015716A1,WO2017004591A3,AU2016287754A1,IL256395D0,KR20180022971A,MX2017016251A,EP3317294A2,CN108026146A,BR", "Patent Title": "Stabilized Anti-microbial Peptides", "Abstract": "The present invention provides methods of designing and making structurally stabilized anti-microbial peptides for the prophylaxis and treatment of infection. Methods are also disclosed for designing stabilized anti-microbial peptides that are selectively lytic/cytotoxic to bacteria, allowing for internal use of anti-microbial peptides without mammalian membrane disruption and cytotoxicity."}], "Sequence Information": {"SPADE ID": "SPADE_N_01509", "Peptide Name": "Dermaseptin-1 (DS I; Dermaseptin-S1, DS1; Frogs, amphibians, animals)", "Source": "Phyllomedusa sauvagei (Sauvage's leaf frog)", "Family": "Belongs to the frog skin active peptide family (Dermaseptin subfamily)", "Gene": "Not found", "Sequence": "ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ", "Sequence Length": 34, "UniProt Entry": ["http://www.uniprot.org/uniprot/P24302", "http://www.uniprot.org/uniprot/P80277"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-", "Antifungal", "Antiprotozoal"], "Target Organism": "Fungi:Microsporum canis (IP 1194) (MIC=50 µg/ml), Tricophyton rubrum (IP 1400-82) (MIC=100 µg/ml), Arthroderma simii (IP 1063-74) (MIC=100 µg/ml), Aspergillus fumigatus (IP 1025-70) (MIC=100 µg/ml), Aerornonas caviae IP (67-16) T (MIC=50 µg/ml), Cryptococcus neoformans (IP 960-67) (MIC=15 µg/ml), Cryptococcus neoformans (IP 962-67) (MIC=15 µg/ml), Candida albicans (IP 884-65) (MIC=60 µg/ml);Gram-negative bacterium:Escherichia coli (IP 76-24) (MIC=5 µg/ml);Gram-positive bacterium:Nocardia brasiliensis (IP 16-80) (MIC=200 µg/ml).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented", "Binding Target": "Cell membrane", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C152H257N43O44S2", "Mass": 3455.06, "PI": 10.0, "Net Charge": 4, "Hydrophobicity": 0.19, "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour", "Function": "Possesses a potent antimicrobial activity against bacteria, fungi and protozoa. Probably acts by disturbing membrane functions with its amphipathic structure. This peptide could also inhibit HIV infection at a concentration that is also toxic to T cells (J Virol 2005; 79", "Tissue specificity": "Expressed by the skin glands.", "Literature": [{"Title": "Isolation, amino acid sequence, and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin.", "Pubmed ID": "1909573", "Reference": "Biochemistry. 1991 Sep 10;30(36)8824-8830.", "Author": "Mor A, Nguyen VH, Delfour A, Migliore-Samour D, Nicolas P.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=1909573"}, {"Title": "Isolation and structure of novel defensive peptides from frog skin.", "Pubmed ID": "8306981", "Reference": "Eur J Biochem. 1994 Jan 15;219(1-2)145-154.", "Author": "Mor A, Nicolas P.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=8306981"}], "Frequent Amino Acids": "ALG", "Absent Amino Acids": "CEFNOPRUVY", "Basic Residues": 5, "Acidic Residues": 1, "Hydrophobic Residues": 17, "Polar Residues": 20, "Positive Residues": 5, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_11578", "Similarity": 1.0, "Sequence": "ALWKTMLKKLGTMAL"}, {"SPADE_ID": "SPADE_N_11582", "Similarity": 1.0, "Sequence": "KALWKTMLKKLGTMAL"}, {"SPADE_ID": "SPADE_UN_13101", "Similarity": 1.0, "Sequence": "ALWKTMLKKLGTMLHAGKALGAAADTISQGTQ"}]}}}